Nasal nitric oxide (nNO) in paediatric primary ciliary dyskinesia (PCD) and in healthy children - On the lookout for optimal cut-off and reference range

Marcin Mikoś (Poznan, Poland), Marcin Mikos, Irena Wojsyk-Banaszak, Magdalena Roszak, Anna Breborowicz

Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Disease area: Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Marcin Mikoś (Poznan, Poland), Marcin Mikos, Irena Wojsyk-Banaszak, Magdalena Roszak, Anna Breborowicz. Nasal nitric oxide (nNO) in paediatric primary ciliary dyskinesia (PCD) and in healthy children - On the lookout for optimal cut-off and reference range. Eur Respir J 2016; 48: Suppl. 60, 3559

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relationship between age and online nasal nitric oxide measured using different techniques in children with suspected primary ciliary dyskinesia
Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease
Year: 2013


The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015


Inflammatory patterns in asthmatic children based on the measurement of alveolar nitric oxide
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013


Limitations of nasal nitric oxide as a screening method of primary ciliary dyskinesia in childhood
Source: International Congress 2016 – Monitoring airway diseases with different tools
Year: 2016


Reference values for offline exhaled and nasal nitric oxide in healthy children
Source: Annual Congress 2013 –Assessing sleep disordered breathing and lung function in children
Year: 2013

Exhaled nitric oxide reference values in healthy Tunisian adults
Source: Annual Congress 2013 –Various issues in clinical respiratory physiology
Year: 2013

Gaz exchange, nasal nitric oxyde levels and lung function tests in children with primary ciliary dyskinesia
Source: International Congress 2015 – Respiratory physiology in children: technical and clinical aspects
Year: 2015


Alveolar nitric oxide and its role in asthma control assessment
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013


New portable nasal nitric oxide (nNO) analyser differentiates primary ciliary dyskinesia (PCD) from healthy individuals.
Source: International Congress 2017 – Primary ciliary dyskinesia and air pollution
Year: 2017


Nasal nitric oxide is low early in life: case study of two infants with primary ciliary dyskinesia
Source: Eur Respir J 2004; 24 : 881-883
Year: 2004



Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013

Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016

Effective patient selection for PCD diagnostics; the PICADAR score with nasal nitric oxide
Source: International Congress 2016 – Highlights in primary ciliary dyskinesia and asthma in childhood
Year: 2016


Nasal nitric oxide measurement and a score of key clinical features for the screening of primary ciliary dyskinesia in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016

Alveolar nitric oxide (CalvNO) measurement. Reference values in healthy people
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008


Nasal nitric oxide measurement in 39 children consecutively referred for primary ciliary dyskinesia work up
Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome
Year: 2007


Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016

Choice of nasal nitric oxide technique as first-line test for primary ciliary dyskinesia
Source: Eur Respir J 2011; 37: 559-565
Year: 2011



Economic evaluation of fractional exhaled nitric oxide (FENO) for the management of adult asthma in Spain
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015